Gateway Analytical Promotes 1-Day Turnaround for Analytical Services at 14th Annual Contract Pharma Conference

Share Button

PITTSBURGH, September 14, 2015 — Gateway Analytical announced today that they will be exhibiting at the 14th Annual Contract Pharma 2015 Contracting and Outsourcing Conference in New Brunswick, New Jersey on September 17th and 18th. The conference is focused on helping to address challenges that today’s drug manufacturers face, such as the increasing pressure to grow and evolve beyond strategies of the past, understanding new technologies, heightened regulatory guidelines, and the continuous growth of generic products.

The Contract Pharma Conference offers educational and networking opportunities for industry leaders in the pharmaceutical and biopharmaceutical manufacturing. “This will be our first year exhibiting at the Contract Pharma Conference and we are looking forward to participating in the different regulatory and quality focused discussions,” said David Exline, Senior Vice President at Gateway Analytical. “We recognize that manufacturers often need analytical support at many different levels and with our wide range of technology and expertise in both common and specialized areas such as foreign particulate identification and glass delamination analysis, Gateway Analytical is in a good position to be able to support drug manufacturers throughout their entire process.”

During the conference, Gateway Analytical will be promoting a wide array of analytical testing services that focus on supporting pharmaceutical drug manufacturing quality control including particulate contamination identification, root cause analysis, glass delamination analysis, deviation, and out-of-specification investigation support. Of particular interest to conference attendees is Gateway Analytical’s ability to give preliminary results in as little as 24 hours with a final analytical report available in 48 hours in some cases.

Gateway Analytical is a full service, cGMP compliant, FDA registered and inspected laboratory with specialized expertise in techniques for chemically specific analysis and particulate contamination identification. For more information on Gateway Analytical pharmaceutical investigation services, contact Karen Sutch, Business Development Manager at sutchk@gatewayanalytical.com.

###

About Gateway Analytical

Based in Gibsonia, Pa., Gateway Analytical, LLC partners with companies in need of high-quality laboratory analysis that do not have the time, resources or capabilities for specialized, comprehensive testing. Through conventional and innovative testing methods, the company provides expert laboratory services and analytical solutions for the pharmaceutical, forensic and materials science industries.

Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.

 

About ChemImage

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage’s headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

Tifanie Tiberio has over 10 years of experience providing marketing communications and events planning for products and services in the pharmaceutical, biopharmaceutical, material science, forensic and threat detection markets. As the Marketing Events and Public Relations Manager for Gateway Analytical, she is responsible for implementation of all marketing efforts which include advertising, special events, exhibits, e-communications, and webinars.

Leave a Reply